Unbelivable.
The report showings nothing but significant growth for every metric - revenue, EBITDA, NPAT - yet the outlook for FY22 NPAT is downgraded dramatically, to be 10% less than FY21!!??!!
WTF?
No explaination except some vague reference to increased employee costs. Arrogant, opaque, confusing. I only have a hold rating because I am too far in the red to sell.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.13 |
Change
0.015(0.71%) |
Mkt cap ! $954.9M | |||
| Open | High | Low | Value | Volume |
| $2.12 | $2.15 | $2.09 | $1.883M | 890.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 14753 | $2.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.13 | 13192 | 18 |
View Market Depth
| Last trade - 14.49pm 29/07/2025 (20 minute delay) ? |
| BVS (ASX) Chart |